Clinical Trial Update: A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating MK-0249 with an Alzheimer's disease medication in adults with Alzheimer’s disease and dementia was terminated; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• MK-0249 (MK-0249)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer's Disease, Dementia | Phase 1 | Status: TERMINATED | Results posted: 2015-06-08